Impact of the National Service Framework for coronary heart disease on treatment and outcome of patients with acute coronary syndromes

Assessment of Myocardial Reperfusion Quality in Patients With Acute Coronary Syndrome and St Segment Elevation, Based on the Criteria by the American College of Cardiology/American Heart Association

“…• диагноз при поступлении -"ОКС", "ИМ" или "нестабильная стенокардия (НС)"; Анализ качества мероприятий по реваскуляризации миокарда в группе (гр.) больных ОКС↑ST проводился с использованием критериев АСС/АНА 2008 г [5]. Использовались следующие показатели:…”

“…Реализация государственной программы улучшения качества МП больным с ОКС позволила добиться достоверного снижения смертности среди больных с ОКС. Согласно данным [4] в США 30-суточная смертность при остром инфаркте миокарда (ОИМ) снизилась с 10,5% в 1999г до 7,8% в 2008 г. Было показано снижение госпитальной летальности при ОКС с 4,8% в 1998г до 3,2% в 2002г (р<0,02), и установлена достоверная связь наблюдаемой тенденции с публикацией Национальной стратегии -National Service Framework (NSF) в 2000г [5].…”

The National Service Framework: six years on

“…Graham and his colleagues 7 contribute a valuable answer to this question in this issue of Heart with a retrospective study on patients with acute coronary syndromes admitted to two coronary care units in East London. Their findings suggest that the NSF contributed to a reduction in mortality due to a highly significant reduction in Q wave myocardial infarction and left ventricular failure.…”

Impact of health care initiatives on outcomes of acute coronary syndromes

“…In a recent study providing the first report examining the impact of the NSF for coronary heart disease on emergency treatment, quality indicators, and outcomes in patients presenting with acute coronary syndromes, data collected before institution of the NSF were compared to data collected after its implementation. 11 The authors found that after the NSF became operational there was an increase in the use of b blockers, ACE inhibitors, and statins, and an increase in the proportion of patients referred for invasive investigation. In addition, there was a significant reduction in time to treatment in patients receiving thrombolysis.…”